tradmap

MACD Bearish Stocks · Services-Commercial Physical & Biological Research

7 stocks match the MACD Bearish Stocks screen. Stocks whose MACD line is below its signal line — a bearish momentum state, largest first. Filtered to Services-Commercial Physical & Biological Research. Data as of close · Checked

Filters2
1–7 of 7
IQVIQVIA0.738.94-1.29%-0.53%+26.15%Golden48.0136.7%BearishBearish-6.83%+71.44%+0.99%Double BottomHammer264.87+0.43%
MEDPMedpace Holdings, Inc.0.6221.91-1.59%+2.16%+19.81%Golden47.9930.0%BearishBullish-8.45%+69.35%-0.05%Double Bottom—635.08-3.25%
CRLCharles River Laboratories1.1216.34-5.36%+2.66%+39.70%Golden45.2619.3%BearishBullish-17.51%+113.98%+0.53%——312.93-4.10%
ABSIAbsci Corp3.541.01-4.62%-2.29%+41.12%Golden46.7225.5%BearishBearish-25.50%+316.74%-3.52%——9.34-11.10%
OABIOmniAb, Inc.1.090.35-1.19%+2.84%+74.37%Golden49.5041.8%BearishBullish-11.15%+267.94%+0.68%Symmetrical TriangleBearish Marubozu4.82-6.86%
MXCTMAXCYTE, INC.1.210.11-5.37%+2.94%+21.65%Golden46.395.2%BearishBullish-27.98%+101.99%-1.81%——1.30-5.80%
IBACIB Acquisition Corp.0.010.15-0.85%+0.70%——48.412.5%BearishNeutral-6.80%+3.34%-0.69%——10.83-0.69%

Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.

Cite this data: “MACD Bearish Stocks”, tradmap.com, data as of 2026-11-05 — tradmap.com/screener/macd-bearish-stocks. Free to cite with attribution and a link.